Although plasma lactate concentration has been widely used as an indicator of tissue hypoxia, no clinical study has been conducted to relate these values to the neurological outcome of sick neonates. Seventeen consecutively cared for and surviving neonates with severe hypoxaemia requiring extracorporeal membrane oxygenation (ECMO) were evaluated at a mean age of 19*6 months. The serial plasma lactate concentrations were significantly correlated with the scores of the Bayley Scales of Infant Development. Admission and peak plasma lactate of a15 mmol/l predicted favourable outcome (MDI and PDI >70 and no disability): sensitivity 100%, specificity 88%, positive predictive value 900/o, and negative predictive value 1000/o.
Severe hypoxaemia in neonates is associated with high mortality and morbidity. Extracorporeal membrane oxygenation (ECMO) has been successfully used as rescue treatment for these newborns with survival rates of about 80% from an international e:xperience of more than 9000 neonatal ECMO cases reported.'
There is limited information available on different risk factors that best predict the outcome of infants receiving ECMO.24 Hyperlactataemia is caused by increased production and defective utilisation as both pathways of lactate metabolism are oxygen dependent.5 Therefore, lactate has been used as an indicator of tissue hypoxia. An association with organ damage in hyperlactataemia is supported by animal hypoxic models,6 7 In this study, abnormal score in either MDI or PDI was defined as a standard score of >2 SD below the mean of normative data No significant correlations were found between the scores of BSID-II and other clinical and biochemical measurements, but the plasma lactate values, on admission, at peak, and 12 hours after starting ECMO were significantly correlated with MDI (r=-0-79 (P<0-001), r=-0-58 (P=0-01), r=-0-71 (P=0-001), respectively); and PDI (r=-0 75 (P<0-001), r=-0-58 (P=0-01), r=-0-62 (P<0-01), respectively) (<601). There were no significant correlations between plasma lactate values and PaO2, 01, pH and serum bicarbonate concentrations. The serial plasma lactate concentrations of disabled or delayed survivors were also significantly higher than those of normal neurodevelopment (table 2) .
Using best subsets regression to analyse the following variables -serial plasma lactate and admission PaO2 -the values of MDI and PDI could be best predicted with plasma lactate values, on admission and 12 hours after starting ECMO (adjusted r2=0 70 and 0-58, respectively). The PaO2 on admission significantly improved the prediction of MDI but not PDI (adjusted r2 to 0-78 and P=0 03, adjusted r2 to 061 and P=019, respectively).
Using an admission plasma lactate value of S 15 mmol/l to predict favourable neurodevelopmental outcome (MDI and PDI ¢70 and no disability, prevalence 53%), the sensitivity and specificity were 100% and 63%, with positive and negative predictive values of 75% and 100%, respectively. The addition of peak plasma lactate S 15 mmol/l improved the specificity to 88% and positive predictive value to 90% (figure). The association between congenital diaphragmatic hernia and adverse neurodevelopment is consistent with other reports. '5 Plasma lactate values could be a useful tool in the prognosis of outcome. Other available clinical and biochemical measurements did not seem to be useful. Further prospective studies are required to evaluate the predictive value of hyperlactataemia in these critically ill neonates.
